SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-100902
Filing Date
2024-04-18
Accepted
2024-04-18 17:01:53
Documents
13
Period of Report
2024-04-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d823295d8k.htm   iXBRL 8-K 20929
  Complete submission text file 0001193125-24-100902.txt   145478

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sana-20240418.xsd EX-101.SCH 2830
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sana-20240418_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sana-20240418_pre.xml EX-101.PRE 11694
16 EXTRACTED XBRL INSTANCE DOCUMENT d823295d8k_htm.xml XML 3772
Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39941 | Film No.: 24854933
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)